MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • A Cross-sectional Gender Gap Meta-analysis in Movement Disorders Publishing Field

    D. Garg, Z. Aldaajani, M. Auffret, T. Capato, M. Picillo, C. Trenkwalder, L. Ali, M. Armstrong, M. Bruno, V. Bruno, E. Minakawa, W. Kamel, S. Fox, D. Olszewska (New Delhi, India)

  • A Dance with Sydenham, it’s Never Too Late to Tango

    M. Gomez Rodriguez, B. Cheon, S. Kenniff (Pembroke Pines, USA)

  • A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS

    C. van Horne, G. Quintero, J. Hixson (Lexington, USA)

  • A Double-Blind, Cross-Over Pilot Study Comparing Adaptive Deep Brain Stimulation (aDBS) to Conventional DBS in Parkinson’s Disease

    T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)

  • A Four-Arm Randomized Controlled Trial on the Effects of Multi-Dimensional Cognitive Intervention in Parkinson’s Disease with Mild and Subjective Cognitive Decline (REMIND)

    P. Huang, C. Gao, YY. Tan, SD. Chen (Shanghai, China)

  • A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease

    D. Chouhan, A. Bello, K. Cullen, J. Duda (Philadelphia, USA)

  • A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies

    C. Gibbons, T. Levine, B. Bellaire, R. Freeman (boston, USA)

  • A mindfulness-based intervention course in pre-manifest Huntington’s disease: analysis of pilot data

    S. Berman, R. Devenyi, V. Vaughn, G. Toti, A. Lasker (Camden, USA)

  • A Mixed Reality Multimodal System for Objective Assessment of Motor and Cognitive Functions in Neurodegenerative Diseases

    D. Hemmerling, J. Stepien, W. Szecowka, A. Channarayapatna Srinivasa, M. Rudzińska-Bar, M. Wojcik-Pedziwiatr, . (Krakow, Poland)

  • A multi-center, randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson’s disease (DATSZ-PD study)

    M. Takahashi, J. Koh, T. Shimokawa, Y. Kajimoto, T. Takeshima, H. Ito (Hirakata, Osaka, Japan)

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley